ArticlePatterns (New York, N.Y.)2026
Keeping generative artificial intelligence reliable in omics biology.
Article in Patterns (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mapping ovarian cellular and molecular landscape across the lifespan of women: a scoping review.Human reproduction update · 2026Article
- Multi-omics-driven precision medicine.iMeta · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generative artificial intelligence can be used to create realistic new data, even for complex real-world processes that cannot be exhaustively modeled: the model is simply learned from preexisting data. Generative artificial intelligence is therefore expected to be a game changer in omics research, where data collection is hampered by considerable experimental constraints. However, it can also "hallucinate"-i.e., create data that are too original to be realistic-which is a critical issue in molecular biology, as hallucinated inferences could have devastating consequences. The author thus explores various use cases to mitigate hallucination-induced risks and to safely unleash the full potential of generative methods.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.